--- title: "Sinocare Inc. (300298.SZ)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/300298.SZ.md" symbol: "300298.SZ" name: "Sinocare Inc." industry: "Health Care Equipment" datetime: "2026-05-20T18:47:12.516Z" locales: - [en](https://longbridge.com/en/quote/300298.SZ.md) - [zh-CN](https://longbridge.com/zh-CN/quote/300298.SZ.md) - [zh-HK](https://longbridge.com/zh-HK/quote/300298.SZ.md) --- # Sinocare Inc. (300298.SZ) ## Company Overview Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Exchange | CN Market | | Website | [www.sinocare.com](https://www.sinocare.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: B > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-20T04:30:11.000Z **Overall: B (0.38)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 14 / 64 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: B #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 8.63% | | | Net Profit YoY | -62.76% | | | P/B Ratio | 3.19 | | | Dividend Ratio | 1.28% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 9507811206.30 | | | Revenue | 4865783269.53 | | #### Multi Score Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 3.62% | C | | Profit Margin | 2.43% | C | | Gross Margin | 52.51% | B | | Revenue YoY | 8.63% | B | | Net Profit YoY | -62.76% | D | | Total Assets YoY | -3.38% | D | | Net Assets YoY | -11.16% | E | | Cash Flow Margin | 384.00% | A | | OCF YoY | 8.63% | B | | Turnover | 0.82 | B | | Gearing Ratio | 40.94% | C | ```chart-data:radar { "title": "Longbridge Financial Score - Sinocare Inc.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "8.63%", "rating": "" }, { "name": "Net Profit YoY", "value": "-62.76%", "rating": "" }, { "name": "P/B Ratio", "value": "3.19", "rating": "" }, { "name": "Dividend Ratio", "value": "1.28%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "9507811206.30", "rating": "" }, { "name": "Revenue", "value": "4865783269.53", "rating": "" } ] }, { "name": "Multi Score", "grade": "B", "indicators": [ { "name": "ROE", "value": "3.62%", "rating": "C" }, { "name": "Profit Margin", "value": "2.43%", "rating": "C" }, { "name": "Gross Margin", "value": "52.51%", "rating": "B" }, { "name": "Revenue YoY", "value": "8.63%", "rating": "B" }, { "name": "Net Profit YoY", "value": "-62.76%", "rating": "D" }, { "name": "Total Assets YoY", "value": "-3.38%", "rating": "D" }, { "name": "Net Assets YoY", "value": "-11.16%", "rating": "E" }, { "name": "Cash Flow Margin", "value": "384.00%", "rating": "A" }, { "name": "OCF YoY", "value": "8.63%", "rating": "B" }, { "name": "Turnover", "value": "0.82", "rating": "B" }, { "name": "Gearing Ratio", "value": "40.94%", "rating": "C" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 79.29 | 39/64 | 38.59 | 36.84 | 34.20 | | PB | 3.15 | 36/64 | 3.75 | 3.27 | 3.02 | | PS (TTM) | 1.93 | 4/64 | 2.65 | 2.22 | 1.99 | | Dividend Yield | 1.30% | 22/64 | 1.29% | 1.17% | 1.03% | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | APT (688617.SH) | A | B | B | A | B | A | | 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B | | 03 | iRay (688301.SH) | B | A | D | C | A | B | | 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B | | 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-05-08T16:00:00.000Z Total Analysts: **5** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 4 | 80% | | Overweight | 1 | 20% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 16.73 | | Highest Target | 23.30 | | Lowest Target | 22.21 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300298.SZ/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300298.SZ/norm.md) - [Related News](https://longbridge.com/en/quote/300298.SZ/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300298.SZ/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**